WebAug 11, 2024 · In June 2024, Novan announced the closing of a registered direct offering with an institutional investor of approximately $15.0 million in total gross proceeds, priced at-the-market under Nasdaq rules. As of June 30, 2024, Novan had a total cash and cash equivalents balance of $37.3 million. WebMar 16, 2024 · H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds to Novan from this offering are approximately $6.0 million, before deducting the placement agent's ...
EPI Health, a Novan Company, and MC2 Therapeutics Present …
WebMar 11, 2024 · Such forward-looking statements speak only as of the date of this press release, and Novan disclaims any intent or obligation to update these forward-looking statements to reflect events or circumstances after the date of such statements, except as may be required by law. INVESTOR AND MEDIA CONTACT: Jenene Thomas JTC Team, … WebFeb 28, 2024 · --Novan, Inc. today announced the pricing of the Company's previously announced underwritten public offering of 18,333,334 shares of common stock and warrants to purchase an aggregate of ... on tech draw
Novan Reports Full Year 2024 Financial Results and …
WebMar 23, 2024 · DURHAM, N.C., March 23, 2024 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2024 financial results on Thursday ... WebJan 6, 2024 · The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, (BUSINESS WIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Novan ... WebMar 16, 2024 · Novan Announces Closing of $6.0 Million Registered Direct Offering by Globe Newswire March 16, 2024 4:15 PM 4 min read DURHAM, N.C., March 16, 2024 (GLOBE NEWSWIRE) -- Novan, Inc. ("the... ontech dish network